PURPOSE We reviewed the evidence that benign prostatic hyperplasia is a progressive condition and men at risk for benign prostatic hyperplasia disease can be identified, treated and protected to a meaningful extent regardless of symptom status. MATERIALS AND METHODS The MEDLINE database was searched in 4 areas of interest relating to benign prostatic hyperplasia, including 1) progression of c...

Benign prostatic hyperplasia is a histological diagnosis and the most frequent benign tumor in older men, its incidence strongly correlates with advanced age. Giant prostate enlargement (GPE), also known as giant hyperplasia, term given for severely enlarged prostates that weigh more than 500g. GPE cases reported literature less 30. We describe our experience of removing previously asymptomatic...

Background and objectivesNumerous clinical studies over recent years have reported an inverse relationship between benign prostatic hyperplasia (BPH) size the incidence of prostate cancer (PCa), leading to hypothesis that expanding BPH zone damages glandular tissue where PCa predominately develops. This systematic review aims establish a historical basis reference on zonal origin (PCa) within p...

To evaluate the Quality of Life (QoL), overall satisfaction, neurodegenerative dimension, and role comorbidities among men diagnosed with Parkinson’s disease PD, Erectile Dysfunction (ED) Benign Prostate Hyperplasia (BPH) in United States.

Benign prostatic hyperplasia (BPH) is a common disease in human that gradual overgrowth of the prostate gland leads to impinge on the urethra with impairment in urinary function. Numerous plants improve uncontrolled growth of the prostate gland and improve urinary tract symptoms associated with BPH. In this study, 25 healthy adult male Wistar rats were divided randomly in five groups: G1 (Contr...

To evaluate the Quality of Life (QoL), overall satisfaction, neurodegenerative dimension, and role comorbidities among men diagnosed with Parkinson’s disease PD, Erectile Dysfunction (ED) Benign Prostate Hyperplasia (BPH) in United States.

According to current guidelines, the surgical treatment of benign prostatic hyperplasia is main therapeutic option, being refractory conservative approach. Transurethral resection prostate and open transvesical adenomectomy have been considered a reference standard in medium (<80ml) large (> 80ml) hyperplasia. To reduce postoperative complications promote faster recovery, there proposed s...

Objective: The purpose of this study is to explore further a new minimally invasive method in order expand the surgical options for treating patients with benign prostatic hyperplasia as well evaluate efficacy and safety endovascular superselective embolization arteries hyperplasia. Material methods: group included 43 hyperplasia, aged 56 90 years. carried out period from February December 2019...

"Giant hyperplasia" of the prostate is a rare pathology of the prostate gland. We report one such case, in which a successful retropubic prostatectomy was performed on an elderly male patient in Pakistan. The weight of the resected prostate was 700 g, which is the eighth largest prostate with benign prostatic hyperplasia reported.